Also because FBXW7 is involved in the response to immunosuppressive7 and chemotherapeutic agents6, germline FBXW7 genetic testing should be considered in individuals affected with atypical WT and early RCC where a complex clinical picture exists. Here, FBXW7 is linked to renal cell adenocarcinoma.